MISSISSAUGA, ON, July 28, 2023 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its financial results for the second quarter of 2023 on Thursday, August 10, 2023. The Company will also host a conference call on Friday, August 11, 2023 at 8:30am ET to discuss the results and corporate developments.
CONFERENCE CALL DETAILS
DATE: | Friday, August 11, 2023 |
TIME: | 8:30 a.m. ET |
DIAL-IN NUMBER: | (416) 764-8650 or (888) 664-6383 |
CONFERENCE ID: | 40452017 |
REPLAY DIAL-IN: | (888) 390-0541 (playback 959756#) |
| Expires August 18, 2023 |
WEBCAST: | https://app.webinar.net/l8n1YB8qokM |
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
View original content: http://www.newswire.ca/en/releases/archive/July2023/28/c7072.html
James Bowen, CFA, Investor Relations - Cipher Pharmaceuticals, James.Bowen@loderockadvisors.com, (416) 519-9442